Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- 最新申報
- 2024/11/14
2022 年第 1 季持倉
持倉截至 2022/3/31，2022/5/16 申報。只含多頭部位，變化是跟 2021 年第 4 季比股數。
- 持股檔數
- 39
- 較 2021 年第 4 季 −4
- 總值
- $2.02 億
- 較 2021 年第 4 季 −$5,931 萬 (−22.7%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ASNDAscendis Pharma A/S | SPONSORED ADR | 140,000 | $1,643 萬 | 8.1% | −50,000−26.3% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,700,000 | $1,273 萬 | 6.3% | 00.0% | 不變 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 250,000 | $1,270 萬 | 6.3% | −75,000−23.1% | 減碼 | 歷史 |
| MRUSMerus N.V. | COM | 400,000 | $1,058 萬 | 5.2% | +50,000+14.3% | 加碼 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 1,100,000 | $1,042 萬 | 5.2% | +600,000+120.0% | 加碼 | 歷史 |
| SRRASierra Oncology, Inc. | COM NEW | 325,000 | $1,042 萬 | 5.2% | +75,000+30.0% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 300,000 | $1,022 萬 | 5.1% | −50,000−14.3% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 466,403 | $862.4 萬 | 4.3% | −33,597−6.7% | 減碼 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 60,000 | $760.7 萬 | 3.8% | +60,000 | 新進 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 450,000 | $757.4 萬 | 3.8% | −175,000−28.0% | 減碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 110,000 | $740.3 萬 | 3.7% | 00.0% | 不變 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 300,000 | $724.5 萬 | 3.6% | +50,000+20.0% | 加碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 400,000 | $664.8 萬 | 3.3% | +150,000+60.0% | 加碼 | 歷史 |
| CTICCti Biopharma Corp | COM | 1,300,000 | $607.1 萬 | 3.0% | +100,000+8.3% | 加碼 | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 350,000 | $569.1 萬 | 2.8% | +350,000 | 新進 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 250,000 | $549.8 萬 | 2.7% | −100,000−28.6% | 減碼 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 100,000 | $438.8 萬 | 2.2% | +100,000 | 新進 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 94,500 | $391.1 萬 | 1.9% | +94,500 | 新進 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 225,000 | $391.1 萬 | 1.9% | −75,000−25.0% | 減碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 50,000 | $390.6 萬 | 1.9% | −50,000−50.0% | 減碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 750,000 | $374.3 萬 | 1.9% | 00.0% | 不變 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 80,000 | $369.1 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 200,000 | $323.0 萬 | 1.6% | +65,000+48.1% | 加碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 200,000 | $317.2 萬 | 1.6% | −225,000−52.9% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 100,000 | $305.7 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 100,000 | $269.9 萬 | 1.3% | −100,000−50.0% | 減碼 | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 150,000 | $254.6 萬 | 1.3% | −50,000−25.0% | 減碼 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 125,000 | $215.5 萬 | 1.1% | −200,000−61.5% | 減碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 120,000 | $201.8 萬 | 1.0% | −50,000−29.4% | 減碼 | 歷史 |
| NMTR9 Meters Biopharma, Inc. | COM | 3,250,000 | $194.8 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 85,000 | $186.6 萬 | 0.9% | −33,344−28.2% | 減碼 | 歷史 |
| STSASatsuma Pharmaceuticals, Inc. | COM | 473,562 | $180.0 萬 | 0.9% | −430,663−47.6% | 減碼 | 歷史 |
| CYPHCypherpunk Technologies Inc. | COM | 993,714 | $173.9 萬 | 0.9% | −356,286−26.4% | 減碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 20,000 | $164.4 萬 | 0.8% | −10,000−33.3% | 減碼 | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 1,315,154 | $163.1 萬 | 0.8% | −684,846−34.2% | 減碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM | 686,599 | $157.9 萬 | 0.8% | +686,599 | 新進 | 歷史 |
| PRDSPardes Biosciences, Inc. | COM | 85,000 | $61.4 萬 | 0.3% | +35,000+70.0% | 加碼 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 100,000 | $40.5 萬 | 0.2% | −125,000−55.6% | 減碼 | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 75,000 | $30.3 萬 | 0.2% | −220,000−74.6% | 減碼 | 歷史 |
選擇權（3 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2021 年第 4 季之後清倉（9 檔）
2021 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 4 季股數 | 2021 年第 4 季市值 | 2021 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 30,000 | $508.7 萬 | 1.9% | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 210,000 | $464.1 萬 | 1.8% | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 450,000 | $362.3 萬 | 1.4% | – |
| KURAKura Oncology, Inc. | COM | 225,000 | $315.0 萬 | 1.2% | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 100,000 | $233.3 萬 | 0.9% | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 60,000 | $175.6 萬 | 0.7% | 歷史 |
| IMUXImmunic, Inc. | COM | 165,000 | $157.9 萬 | 0.6% | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 55,000 | $145.0 萬 | 0.6% | 歷史 |
| CABACabaletta Bio, Inc. | COM | 135,000 | $51.2 萬 | 0.2% | 歷史 |